FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1809432810> ?p ?o ?g. }

• W1809432810 abstract "Background: Procalcitonin (PCT) is a marker for bacterial infection that can be used as a diagnostic tool to help distinguish viral from bacterial lower respiratory tract infections (LRTI). LRTI is a leading cause of illness in pediatrics worldwide. Most LRTIs in pediatrics are due to viral causes, yet conservative clinical guidelines advise empiric antibiotic therapy because there is no reliable method to determine the etiology of the illness. With the increasing threat of antibiotic resistance, efforts are underway to decrease the use of antibiotics. PCT-guided antibiotic therapy has shown a reduction in the use of antibiotics for adult LRTI. Can PCT-guided antibiotic treatment of LRTIs in a pediatric population reduce the antibiotic therapy duration rate or prescription rate with comparable outcomes to current therapy guidelines? Method: An exhaustive search was conducted using Medline-OVID, CINAHL, and Web of Science using the keywords: procalcitonin, antibiotic, pediatrics, and lower respiratory tract infection. A search on the NIH clinical trials site revealed that there are no trials currently registered relating to the use of PCT-guided antibiotic therapy in pediatrics with lower respiratory tract infections. GRADE was used to assess the quality of relevant articles. Results: Included in this systematic review were two studies that met inclusion criteria. A randomized, multi-center clinical trial with 337 participants demonstrated a statistically significant reduction in the duration of antibiotic therapy, but an increase in the antibiotic prescription rate overall when applying PCT-guided antibiotic therapy. A randomized, single-center clinical trial with 310 participants demonstrated a statistically significant reduction in the duration of antibiotic therapy and antibiotic prescription rate when PCT-guided antibiotic therapy was applied. Conclusion: PCT-guided antibiotic therapy has been shown to reduce the duration of antibiotic therapy. Furthermore, it is suggested that in less severe LRTI PCT-guided antibiotic therapy can reduce antibiotic prescription rates in a pediatric population. More randomized control trials are needed to increase the statistical power behind these findings. There was no evidence of increased risk of disease-specific adverse events. At this time PCT-guided therapy is recommended to reduce the duration of antibiotic therapy. Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor David Keene, MPAS, PA-C" @default.
• W1809432810 created "2016-06-24" @default.
• W1809432810 creator A5090194741 @default.
• W1809432810 date "2015-01-01" @default.
• W1809432810 modified "2023-09-27" @default.
• W1809432810 title "The Utility of Procalcitonin-Guided Antibiotic Therapy in the Treatment of Lower Respiratory Tract Infections for Reducing Antibiotic Prescription Rate and Therapy Duration in Pediatrics" @default.
• W1809432810 cites W11152845 @default.
• W1809432810 cites W14515874 @default.
• W1809432810 cites W1970962136 @default.
• W1809432810 cites W1974347586 @default.
• W1809432810 cites W1976049790 @default.
• W1809432810 cites W1986189079 @default.
• W1809432810 cites W2008548231 @default.
• W1809432810 cites W2016354557 @default.
• W1809432810 cites W2018407610 @default.
• W1809432810 cites W2040539669 @default.
• W1809432810 cites W2044142824 @default.
• W1809432810 cites W2063566130 @default.
• W1809432810 cites W2099280130 @default.
• W1809432810 cites W2113629675 @default.
• W1809432810 cites W2114071909 @default.
• W1809432810 cites W2116581803 @default.
• W1809432810 cites W2147634646 @default.
• W1809432810 hasPublicationYear "2015" @default.
• W1809432810 type Work @default.
• W1809432810 sameAs 1809432810 @default.
• W1809432810 citedByCount "0" @default.
• W1809432810 crossrefType "journal-article" @default.
• W1809432810 hasAuthorship W1809432810A5090194741 @default.
• W1809432810 hasConcept C10936531 @default.
• W1809432810 hasConcept C126322002 @default.
• W1809432810 hasConcept C168563851 @default.
• W1809432810 hasConcept C177713679 @default.
• W1809432810 hasConcept C187212893 @default.
• W1809432810 hasConcept C2426938 @default.
• W1809432810 hasConcept C2776012195 @default.
• W1809432810 hasConcept C2776399701 @default.
• W1809432810 hasConcept C2778384902 @default.
• W1809432810 hasConcept C501593827 @default.
• W1809432810 hasConcept C534529494 @default.
• W1809432810 hasConcept C535046627 @default.
• W1809432810 hasConcept C71924100 @default.
• W1809432810 hasConcept C86803240 @default.
• W1809432810 hasConcept C89423630 @default.
• W1809432810 hasConcept C98274493 @default.
• W1809432810 hasConceptScore W1809432810C10936531 @default.
• W1809432810 hasConceptScore W1809432810C126322002 @default.
• W1809432810 hasConceptScore W1809432810C168563851 @default.
• W1809432810 hasConceptScore W1809432810C177713679 @default.
• W1809432810 hasConceptScore W1809432810C187212893 @default.
• W1809432810 hasConceptScore W1809432810C2426938 @default.
• W1809432810 hasConceptScore W1809432810C2776012195 @default.
• W1809432810 hasConceptScore W1809432810C2776399701 @default.
• W1809432810 hasConceptScore W1809432810C2778384902 @default.
• W1809432810 hasConceptScore W1809432810C501593827 @default.
• W1809432810 hasConceptScore W1809432810C534529494 @default.
• W1809432810 hasConceptScore W1809432810C535046627 @default.
• W1809432810 hasConceptScore W1809432810C71924100 @default.
• W1809432810 hasConceptScore W1809432810C86803240 @default.
• W1809432810 hasConceptScore W1809432810C89423630 @default.
• W1809432810 hasConceptScore W1809432810C98274493 @default.
• W1809432810 hasLocation W18094328101 @default.
• W1809432810 hasOpenAccess W1809432810 @default.
• W1809432810 hasPrimaryLocation W18094328101 @default.
• W1809432810 isParatext "false" @default.
• W1809432810 isRetracted "false" @default.
• W1809432810 magId "1809432810" @default.
• W1809432810 workType "article" @default.